• Global Clinical Research & Health Data Analytics Company
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • Webinars
  • MMS Blog
  • Careers
  • Contact Us
MMS Holdings
MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

by Don McLean | Mar 4, 2020 | News

MMS Holdings to Debut Datacise Integrated Safety Explorer to Detect Safety Signals Using Real-World Evidence During PHUSE/FDA Data Science Innovation Challenge CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today...
Recommended Reading from Eight Pharmaceutical Experts This Summer

Recommended Reading from Eight Pharmaceutical Experts This Summer

by Don McLean | Aug 15, 2019 | Blog

Recommended Reading from Eight Pharmaceutical Experts This Summer by Staff Writer Summer reading isn’t reserved for school-aged children, as adults and professionals alike can gain knowledge and insights from consistently reading material during the hottest months of...
Building a robust clinical data science process

Building a robust clinical data science process

by curtis@digitalliance.com | Jun 7, 2018 | Blog

Building a robust clinical data science process by Staff writer During PhUSE US Connect 2018 – the clinical data science conference – in Raleigh, North Carolina, MMS data science experts presented a paper and corresponding poster, titled Big Data Paradox: Development...

Recent Posts

  • Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable”
  • EY Announces Dr. Uma Sharma of MMS Holdings as an Entrepreneur Of The Year® 2020 Michigan and Northwest Ohio Award Finalist
  • MichBio Invites MMS Founder and Chief Scientific Officer Dr. Uma Sharma to Join Board of Directors
  • How Zero Contact GXP Audits Ensure Compliance While Protecting Auditors and Auditees during the Global Pandemic
  • FDA Orphan Drug Designation Applications Whitepaper

Tags

ALZ awareness Alzheimers biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance COVID-19 CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Health Analytics Collective Health Canada Lay summaries leadership medical writing NDA submission opioids pharma pharmacovigilance PhUSE Policy 0070 quality control rare disease real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering